JP Patent

JP2011515472A — ベンダムスチン塩酸塩の新規固体形態

Assigned to セファロン、インク． · Expires 2011-05-19 · 15y expired

What this patent protects

ベンダムスチン塩酸塩の新規の固体形態ならびにそれを調製し、使用する方法が記載される。【選択図】図２

USPTO Abstract

ベンダムスチン塩酸塩の新規の固体形態ならびにそれを調製し、使用する方法が記載される。【選択図】図２

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP2011515472A
Jurisdiction: JP
Classification: —
Expires: 2011-05-19
Drug substance claim: No
Drug product claim: No
Assignee: セファロン、インク．
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.